Document ID: chunk:federal_register_of_legislation:F2021C00952:schedule:1:p9
Version: federal_register_of_legislation:F2021C00952
Segment Type: schedule
Provision Reference: sch 1 (pt 9/10)
Character Range: 23288–26154

for at least the five years before the clinical worsening of ischaemic heart disease;
(60) an inability to sleep for an average of at least five hours daily for at least the one year before the clinical worsening of ischaemic heart disease;
(61) being infected with human immunodeficiency virus for at least five years before the clinical worsening of ischaemic heart disease;
(62) having periodontitis for at least the five years before the clinical worsening of ischaemic heart disease;
(63) having infective endocarditis or syphilis involving the coronary arteries at the time of the clinical worsening of ischaemic heart disease;
(64) undergoing a procedure involving catheterisation of the affected coronary artery within the five years before the clinical worsening of ischaemic heart disease;
(65) having an autoimmune disease from the specified list of autoimmune diseases at the time of the clinical worsening of ischaemic heart disease;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(66) for acute myocardial infarction or sudden death from ischaemic heart disease only:
(a) undertaking physical activity of six METs or more within the 12 hours before the clinical worsening of ischaemic heart disease;
(b) experiencing a category 1A stressor within the 24 hours before the clinical worsening of ischaemic heart disease;
(c) experiencing a category 1B stressor within the 24 hours before the clinical worsening of ischaemic heart disease;
(d) experiencing an acute, severe, emotional stressor within the 12 hours before the clinical worsening of ischaemic heart disease;
(e) experiencing the death of a significant other within the six months before the clinical worsening of ischaemic heart disease;
(f) using a drug from Specified List 2 of drugs within the 24 hours before the clinical worsening of ischaemic heart disease;
(g) having an episode of acute cholinergic poisoning from exposure to an organophosphorus ester within the seven days before the clinical worsening  of ischaemic heart disease;
(h) being exposed to:
(i) an environment of extreme heat during a heatwave; or
(ii) an environment of extreme cold during a cold snap; or
(iii) an abrupt alteration of temperature by ten degrees Celsius or more, to extreme heat or to extreme cold;
             for a period of at least six hours within the seven days before the clinical worsening of ischaemic heart disease;
(i) inhaling ambient highly polluted air as specified for at least two hours within the seven days before the clinical worsening of ischaemic heart disease;
(j) being envenomated by a snake, scorpion, wasp, bee, hornet, spider, fish or jellyfish within the 24 hours before the clinical worsening of ischaemic heart disease;
(k) having an acute hypersensitivity reaction involving the coronary arteries as a result of being exposed to a